Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split…
Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery…
Life EV Group in December 2023 announced its acquisition of a 40% interest in LEV Manufacturing through a share exchange…
The global electric boats market is forecast to more than double in size, increasing from $3.3 billion in 2023 to…
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”) has developed a patent-pending alcohol detection device to detect alcohol in humans with just a…
SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control…
Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.…
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused…
Correlate Energy, a publicly traded distributed energy solutions company, has positioned itself as the go-to company given the federal government’s…